Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Watts

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Investigation|February 13, 2001
Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemiaC A Dane-Stewart, G F Watts, J C Mamo, et al.
Kidney International|June 26, 2001
Vascular function of the peripheral circulation in patients with nephrosisG F Watts, S Herrmann, G K Dogra, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 2019
Implementing simple algorithms to improve glucose and lipid management in people with diabetes and acute coronary syndromeN S R Lan, P G Fegan, J M Rankin, et al.
European Journal of Clinical Investigation|June 13, 2002
Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesityD C Chan, G F Watts, T A Mori, et al.
Clinical Chemistry|August 1, 1986
Assessment of immunochemical methods for determining low concentrations of albumin in urineG F Watts, J E Bennett, D J Rowe, et al.
Clinical and Experimental Pharmacology & Physiology|August 23, 2006
Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studiesG F Watts, D C Chan, E M M Ooi, et al.
Internal Medicine Journal|October 20, 2015
The association between chronic hepatitis C infection and cardiovascular riskP Pateria, G P Jeffrey, G MacQuillan, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patientsD C Chan, S J Hamilton, K A Rye, et al.
Metabolism: Clinical and Experimental|August 1, 1995
Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjectsG F Watts, R Naoumova, M H Cummings, et al.
Internal Medicine Journal|July 14, 2016
Author replyP Pateria, G P Jeffrey, G MacQuillan, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Investigation|February 13, 2001
Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemiaC A Dane-Stewart, G F Watts, J C Mamo, et al.
Kidney International|June 26, 2001
Vascular function of the peripheral circulation in patients with nephrosisG F Watts, S Herrmann, G K Dogra, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 2019
Implementing simple algorithms to improve glucose and lipid management in people with diabetes and acute coronary syndromeN S R Lan, P G Fegan, J M Rankin, et al.
European Journal of Clinical Investigation|June 13, 2002
Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesityD C Chan, G F Watts, T A Mori, et al.
Clinical Chemistry|August 1, 1986
Assessment of immunochemical methods for determining low concentrations of albumin in urineG F Watts, J E Bennett, D J Rowe, et al.
Clinical and Experimental Pharmacology & Physiology|August 23, 2006
Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studiesG F Watts, D C Chan, E M M Ooi, et al.
Internal Medicine Journal|October 20, 2015
The association between chronic hepatitis C infection and cardiovascular riskP Pateria, G P Jeffrey, G MacQuillan, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patientsD C Chan, S J Hamilton, K A Rye, et al.
Metabolism: Clinical and Experimental|August 1, 1995
Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjectsG F Watts, R Naoumova, M H Cummings, et al.
Internal Medicine Journal|July 14, 2016
Author replyP Pateria, G P Jeffrey, G MacQuillan, et al.
Pageof 20